Clinical Trials Browser

INDUSTRY × Interventional × monoclonal antibody YYB-101 × Clear all

NCT04368507 2022-11-14

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients

Phase 1/2 Completed

Gastrointestinal

Colorectal Cancer Metastatic

NCT02499224 2021-05-13

Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

Phase 1 Completed

Other solid neoplasm

Solid Tumors